Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
RyboDyn has received $1.3 million from the U.S. Department of War to advance two antibody therapies for lung cancer, supporting preclinical development of programs based on targets discovered through its AI-powered CypherAtlas platform.
Sanyou Biopharmaceuticals has released GEOTA 1.0, a new digital computing platform within its SAI-DA program that simplifies access to AI-driven research tools for drug development.
Lucile Packard Children's Hospital Stanford has implemented R-Zero's Physical AI platform to optimize HVAC operations using real-time occupancy data. The system integrates with existing building management infrastructure to cut energy use by up to 40%.
Children’s Hospital of Philadelphia has been awarded up to $38.9 million over five years from ARPA-H’s THRIVE program to develop personalized gene editing therapies for rare liver-related genetic disorders.
Collectly has introduced its AI agent Billie and revenue cycle management platform on Epic's Connection Hub, offering healthcare providers automated patient billing, flexible payment plans, and 24/7 AI support without disrupting existing Epic workflows.
Movemedical has launched Ask Move AI, a mobile AI assistant designed to help medical device field representatives manage surgical case workflows using conversational interfaces on mobile devices.
Evogene and Tel Aviv University's Blavatnik Center for Drug Discovery have formed a joint initiative to support academic ventures in small molecule drug discovery, combining computational chemistry with experimental validation.
LifeLoop has launched Olia, an AI companion designed for life enrichment professionals in senior living communities. The tool supports staff with resident engagement, care continuity, and administrative tasks and will be available this fall.
NeuPT Technologies and VINSI.AI have launched ReadyOS, a platform that delivers objective physiological readiness assessments in under 90 seconds to guide clinical treatment decisions.
Pearl Health has raised $110 million to expand its AI platform that helps healthcare providers manage risk and improve care for Medicare patients. The raise includes equity financing led by Andreessen Horowitz and a credit facility from Trinity Capital.
Researchers from TReNDS Center and Amen Clinics report that machine learning models can differentiate individuals with schizophrenia from healthy controls using whole-brain SPECT imaging data.
Aureka has introduced OpenDDE, an open source biomolecular model designed to support AI applications in drug discovery. The model focuses on structural reasoning across proteins, nucleic acids, and small molecules and is available under the Apache-2.0 license.
Brook.ai and SRHO have announced a partnership to deploy Brook's AI remote care platform across more than 275 hospitals in 20 states, enabling continuous patient care beyond hospital settings.
CurifyLabs has raised $14 million in Series A funding co-led by Sandwater and HealthCap to expand its personalized medicine compounding technology in the U.S. and Europe.
Montreal-based AI4Eyes has been accepted into the MEDTEQ+ Avise Program and awarded $700,000 to validate its AI-powered dry eye diagnostic platform in real-world clinical settings.
The FDA has granted clearance for CliniComp's PACS Viewer, allowing diagnostic-quality image viewing and processing within its New Era EHR platform. The system consolidates imaging, clinical workflows, and AI-based decision support into a single patient record.
ONTO Health has acquired LEVY Health to scale its physician-led fertility and longevity care services, following a $20 million Series A funding round. The acquisition will accelerate ONTO Health’s expansion in the United States and the Gulf Cooperation Council region.
Surgical Safety Technologies has rebranded as Aimbient, expanding its AI platform beyond the operating room to enhance efficiency and safety across all hospital procedural environments. The platform, trained on over 15 million hours of procedural data, combines predictive, real-time, and retrospective intelligence to support clinical and operational improvements.
EDETEK has announced a sponsor partnership program to help life sciences organizations participate in the FDA's Real Time Clinical Trials initiative, using its AI enabled R&D Cloud for continuous data oversight and collaboration.
METiS TechBio has entered a global licensing agreement with Boulevard Bio, granting exclusive rights to develop, manufacture, and commercialize MTS-128, an AI designed trispecific T cell engager. The deal includes $20 million upfront and up to $1.6 billion in potential milestone payments.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
